Martens DE - Search Results

1

Bioengineering bacterial outer membrane vesicles as vaccine platform.

Gerritzen MJH, Martens DE, Wijffels RH, van der Pol L, Stork M. Gerritzen MJH, et al. Among authors: martens de. Biotechnol Adv. 2017 Sep;35(5):565-574. doi: 10.1016/j.biotechadv.2017.05.003. Epub 2017 May 15. Biotechnol Adv. 2017. PMID: 28522212 Free article. Review.

2

PAT for vaccines: the first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease.

Streefland M, van de Waterbeemd B, Happé H, van der Pol LA, Beuvery EC, Tramper J, Martens DE. Streefland M, et al. Among authors: martens de. Vaccine. 2007 Apr 20;25(16):2994-3000. doi: 10.1016/j.vaccine.2007.01.015. Epub 2007 Jan 22. Vaccine. 2007. PMID: 17313999

3

Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes.

Baart GJ, Zomer B, de Haan A, van der Pol LA, Beuvery EC, Tramper J, Martens DE. Baart GJ, et al. Among authors: de haan a, martens de. Genome Biol. 2007;8(7):R136. doi: 10.1186/gb-2007-8-7-r136. Genome Biol. 2007. PMID: 17617894 Free PMC article.

4

Scale-up for bulk production of vaccine against meningococcal disease.

Baart GJ, de Jong G, Philippi M, van't Riet K, van der Pol LA, Beuvery EC, Tramper J, Martens DE. Baart GJ, et al. Among authors: martens de, de jong g. Vaccine. 2007 Aug 21;25(34):6399-408. doi: 10.1016/j.vaccine.2007.06.008. Epub 2007 Jun 26. Vaccine. 2007. PMID: 17658670

5

Evaluation of a critical process parameter: oxygen limitation during cultivation has a fully reversible effect on gene expression of Bordetella pertussis.

Streefland M, van de Waterbeemd B, Kint J, van der Pol LA, Beuvery EC, Tramper J, Martens DE. Streefland M, et al. Among authors: martens de. Biotechnol Bioeng. 2009 Jan 1;102(1):161-7. doi: 10.1002/bit.22030. Biotechnol Bioeng. 2009. PMID: 18683249

6

Gene-expression-based quality scores indicate optimal harvest point in Bordetella pertussis cultivation for vaccine production.

van de Waterbeemd B, Streefland M, Pennings J, van der Pol L, Beuvery C, Tramper J, Martens D. van de Waterbeemd B, et al. Among authors: martens d. Biotechnol Bioeng. 2009 Aug 1;103(5):900-8. doi: 10.1002/bit.22326. Biotechnol Bioeng. 2009. PMID: 19405154

7

A practical approach for exploration and modeling of the design space of a bacterial vaccine cultivation process.

Streefland M, Van Herpen PF, Van de Waterbeemd B, Van der Pol LA, Beuvery EC, Tramper J, Martens DE, Toft M. Streefland M, et al. Among authors: martens de. Biotechnol Bioeng. 2009 Oct 15;104(3):492-504. doi: 10.1002/bit.22425. Biotechnol Bioeng. 2009. PMID: 19598176

8

Growth efficiency and carbon balance for the sponge Haliclona oculata.

Koopmans M, Martens D, Wijffels RH. Koopmans M, et al. Mar Biotechnol (NY). 2010 Jun;12(3):340-9. doi: 10.1007/s10126-009-9228-8. Epub 2009 Oct 1. Mar Biotechnol (NY). 2010. PMID: 19795172 Free PMC article.

9

Expression of phosphofructokinase in Neisseria meningitidis.

Baart GJE, Langenhof M, van de Waterbeemd B, Hamstra HJ, Zomer B, van der Pol LA, Beuvery EC, Tramper J, Martens DE. Baart GJE, et al. Among authors: martens de. Microbiology (Reading). 2010 Feb;156(Pt 2):530-542. doi: 10.1099/mic.0.031641-0. Epub 2009 Oct 1. Microbiology (Reading). 2010. PMID: 19797358 Free PMC article.

10

Towards commercial production of sponge medicines.

Koopmans M, Martens D, Wijffels RH. Koopmans M, et al. Mar Drugs. 2009 Dec 2;7(4):787-802. doi: 10.3390/md7040787. Mar Drugs. 2009. PMID: 20098610 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page